10x Genomics, Inc.

10x Genomics, Inc.

TXG
10x Genomics, Inc.US flagNASDAQ Global Select
28.84
USD
-0.21
- -
3.66BMarket Cap

10x Genomics, Inc. (TXG) Stock Split History

Learn about 10x Genomics, Inc.'s most recent 1-for-2 basis stock split on July 17, 2006. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about 10x Genomics, Inc.'s most recent stock split

Split Date: 2006-07-17
Split Ratio: 1:2
Price Before Split: N/A
Price After Split: N/A

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 2.00 times fewer shares (a 1:2 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of 10x Genomics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2006-07-171:2YesN/AN/A

About 10x Genomics, Inc.

Company overview and industry information

10x Genomics, Inc. (TXG) operates in the Medical - Healthcare Information Services industry. The recent 1-for-2 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Medical - Healthcare Information Services
Go to 10x Genomics, Inc. Summary

Last updated: 6/15/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.